MINNEAPOLIS--(BUSINESS WIRE)--Medtronic Inc. (NYSE:MDT) today announced the start of its CONNECT SM trial, which will further substantiate the impact of Medtronic’s most advanced devices with Conexus™ ...

MiniMed Connect Mobile Accessory Provides Easier and Better Access to Pump and CGM Data, Helping Optimize Therapy for Improved Glycemic Patterns DUBLIN - October 24, 2016 - Medtronic plc (MDT), the ...

Medtronic Furthers Move toward Holistic Diabetes Management by Integrating Devices, Data and Consumer Technology DUBLIN - September 28, 2015 - Medtronic plc (MDT), the global leader in medical ...

DUBLIN, May 22, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of ...

I recently had the chance to try out the latest in diabetes tech from Medtronic, conducting a 14-day test drive of the new Minimed Connect data display platform. This new system shows both insulin ...

Medtronic plc MDT announced the receipt of FDA approval for the Guardian Connect continuous glucose monitoring (CGM) system for diabetes patients between the ages of 14 to 75 years. Notably, the ...

Medtronic plc. MDT recently made a major development in the field of diabetes management. The company reached an outcome-based agreement with Blue Cross and Blue Shield of Minnesota in relation to the ...

The data presented were recorded from people who use the Guardian Connect system paired with Sugar.IQ diabetes assistant. The latter is a separate unique intelligent app that continuously analyzes how ...

Medtronic plc (NYSE:MDT) announced the receipt of FDA approval for the Guardian Connect continuous glucose monitoring (CGM) system for diabetes patients between the ages of 14 to 75 years. Notably, ...

Medtronic launches MiniMed 780G with Abbott sensor integration, expanding its diabetes ecosystem ahead of a planned spinoff.